F&P Healthcare overvalued at current price - Forsyth Barr

F&P Healthcare overvalued at current price - Forsyth Barr
Brent Melville
Investment group Forsyth Barr says Fisher & Paykel Healthcare shares are overpriced at current levels and could come back by about $10 over the next 12 months as the world moves to more “industry growth rates” in the wake of covid-19.F&P Healthcare is trading near all-time highs at $29.48, or a market capitalisation of $16.9 billion, making it New Zealand's biggest listed company.An $18.50 price would effectively lop $6 billion off its capitalisation. See more details on NZX.comEquity analyst Chelsea...